Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine plus melphalan conditioning for autologous HSCT in multiple myeloma
ChiCTR2100046675Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bendamustine and melphalan in multiple myeloma (MM), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: Complete remission and above remission rate (≥CR). Started Jun 2021; status: recruiting.
02
Drugs
bendamustinemelphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR2100046675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046675.